DAI CHENGXIANG enters CELLULAR BIOMEDICINE GROUP, INC. with 13.75K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 11/20/2019ACC: 0000902664-19-004399
10% Owner
Since Nov 2019
13.75K
Baseline shares
0.00
Direct ownership
0 positions
50.54K
Derivative underlying
4 instruments
1
Security positions
13.75K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned13.75K
Total
13.75K indirect13.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.75K | Indirect |
| Total | 13.75K | 13.75K indirect |
Derivative Holdings4
Stock Options (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
15K
Shares owned
N/A
Exercise price
18.61
Expiration
—
Exercise window
—
Stock Options (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
26.50K
Shares owned
N/A
Exercise price
12.40
Expiration
—
Exercise window
—
Stock Options (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
200.00
Shares owned
N/A
Exercise price
5.30
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
8.84K
Shares owned
N/A
Exercise price
0.00
Expiration
—
Exercise window
—
Total
Underlying
50.54K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock | 18.61 | — | — | 15K | N/A |
| Stock Options (right to buy) Direct | Common Stock | 12.40 | — | — | 26.50K | N/A |
| Stock Options (right to buy) Direct | Common Stock | 5.30 | — | — | 200.00 | N/A |
| Restricted Stock Units Direct | Common Stock | 0.00 | — | — | 8.84K | N/A |
| Total | 50.54K | 0.00 | ||||